Cargando…
Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study)
BACKGROUND: Despite the availability of effective treatment, the control of hypertension remains insufficient. Telemonitoring in the management of hypertension would be an effective way to improve blood pressure control. OBJECTIVE: The aim of our study will be to evaluate the effects of telemonitori...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924775/ https://www.ncbi.nlm.nih.gov/pubmed/35230254 http://dx.doi.org/10.2196/26184 |
_version_ | 1784669931290230784 |
---|---|
author | Ben Hafaiedh, Sonia Ben Daya, Yosra Radoui, Amina Hadjer Bouchoucha, Mohamed Razgallah, Rabie Nouira, Semir |
author_facet | Ben Hafaiedh, Sonia Ben Daya, Yosra Radoui, Amina Hadjer Bouchoucha, Mohamed Razgallah, Rabie Nouira, Semir |
author_sort | Ben Hafaiedh, Sonia |
collection | PubMed |
description | BACKGROUND: Despite the availability of effective treatment, the control of hypertension remains insufficient. Telemonitoring in the management of hypertension would be an effective way to improve blood pressure control. OBJECTIVE: The aim of our study will be to evaluate the effects of telemonitoring with antihypertensive treatment titration on blood pressure control in Tunisian patients with hypertension. METHODS: Our trial will be a prospective, rater-blinded randomized controlled trial carried out with primary care physicians in the Sahel region of Tunisia. Patients will be eligible for enrollment if they are aged over 35 years, are newly diagnosed with hypertension, or are known to be poorly controlled on antihypertensive therapy. Participants will be randomly assigned in a 1:1 ratio to the telemonitoring arm or usual care arm. The telemonitoring arm will involve a weekly telephone call for the collection of the home blood pressure measurements, therapeutic education, and treatment compliance assessment as well as a monthly call for treatment titration and a side effect check. Randomization will be done via the use of an interactive web responsive system, and patients will be stratified by investigation center. Neither participants nor investigators will be masked to the group assignments. The primary outcome will be the change in mean 24-hour systolic blood pressure from baseline to the 6-month follow-up in the 2 groups. All randomized patients who attend the follow-up visit at 6 months and have no missing data for the primary outcome will be included in the analysis. RESULTS: Recruitment to the trial started in July 2020. The study was initiated with 17 primary care physicians. We expect the inclusion period to last for approximately 6 months. We expect to complete data collection by the end of 2021 and plan to disseminate the results subsequently. CONCLUSIONS: The HOROSCOPE (Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Randomized Controlled Prospective Trial) study will provide important new evidence that could shed some light on the feasibility and impact of telemonitoring and self-monitoring in a Tunisian population of patients with hypertension who consult primary care physicians. TRIAL REGISTRATION: ClinicalTrials.gov NCT04607239; https://clinicaltrials.gov/ct2/show/NCT04607239 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/26184 |
format | Online Article Text |
id | pubmed-8924775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-89247752022-03-17 Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study) Ben Hafaiedh, Sonia Ben Daya, Yosra Radoui, Amina Hadjer Bouchoucha, Mohamed Razgallah, Rabie Nouira, Semir JMIR Res Protoc Protocol BACKGROUND: Despite the availability of effective treatment, the control of hypertension remains insufficient. Telemonitoring in the management of hypertension would be an effective way to improve blood pressure control. OBJECTIVE: The aim of our study will be to evaluate the effects of telemonitoring with antihypertensive treatment titration on blood pressure control in Tunisian patients with hypertension. METHODS: Our trial will be a prospective, rater-blinded randomized controlled trial carried out with primary care physicians in the Sahel region of Tunisia. Patients will be eligible for enrollment if they are aged over 35 years, are newly diagnosed with hypertension, or are known to be poorly controlled on antihypertensive therapy. Participants will be randomly assigned in a 1:1 ratio to the telemonitoring arm or usual care arm. The telemonitoring arm will involve a weekly telephone call for the collection of the home blood pressure measurements, therapeutic education, and treatment compliance assessment as well as a monthly call for treatment titration and a side effect check. Randomization will be done via the use of an interactive web responsive system, and patients will be stratified by investigation center. Neither participants nor investigators will be masked to the group assignments. The primary outcome will be the change in mean 24-hour systolic blood pressure from baseline to the 6-month follow-up in the 2 groups. All randomized patients who attend the follow-up visit at 6 months and have no missing data for the primary outcome will be included in the analysis. RESULTS: Recruitment to the trial started in July 2020. The study was initiated with 17 primary care physicians. We expect the inclusion period to last for approximately 6 months. We expect to complete data collection by the end of 2021 and plan to disseminate the results subsequently. CONCLUSIONS: The HOROSCOPE (Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Randomized Controlled Prospective Trial) study will provide important new evidence that could shed some light on the feasibility and impact of telemonitoring and self-monitoring in a Tunisian population of patients with hypertension who consult primary care physicians. TRIAL REGISTRATION: ClinicalTrials.gov NCT04607239; https://clinicaltrials.gov/ct2/show/NCT04607239 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/26184 JMIR Publications 2022-03-01 /pmc/articles/PMC8924775/ /pubmed/35230254 http://dx.doi.org/10.2196/26184 Text en ©Sonia Ben Hafaiedh, Yosra Ben Daya, Amina Hadjer Radoui, Mohamed Bouchoucha, Rabie Razgallah, Semir Nouira. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 01.03.2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included. |
spellingShingle | Protocol Ben Hafaiedh, Sonia Ben Daya, Yosra Radoui, Amina Hadjer Bouchoucha, Mohamed Razgallah, Rabie Nouira, Semir Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study) |
title | Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study) |
title_full | Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study) |
title_fullStr | Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study) |
title_full_unstemmed | Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study) |
title_short | Home Telemonitoring of Arterial Hypertension With Antihypertensive Treatment Titration: Protocol for a Randomized Controlled Prospective Trial (HOROSCOPE Study) |
title_sort | home telemonitoring of arterial hypertension with antihypertensive treatment titration: protocol for a randomized controlled prospective trial (horoscope study) |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924775/ https://www.ncbi.nlm.nih.gov/pubmed/35230254 http://dx.doi.org/10.2196/26184 |
work_keys_str_mv | AT benhafaiedhsonia hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy AT bendayayosra hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy AT radouiaminahadjer hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy AT bouchouchamohamed hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy AT razgallahrabie hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy AT nouirasemir hometelemonitoringofarterialhypertensionwithantihypertensivetreatmenttitrationprotocolforarandomizedcontrolledprospectivetrialhoroscopestudy |